676 related articles for article (PubMed ID: 26159590)
21. The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose.
Hasselbalch SG; Holm S; Pedersen HS; Svarer C; Knudsen GM; Madsen PL; Paulson OB
J Cereb Blood Flow Metab; 2001 Aug; 21(8):995-1002. PubMed ID: 11487735
[TBL] [Abstract][Full Text] [Related]
22. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
23. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
24. A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT.
Hjelmgren O; Johansson L; Prahl U; Schmidt C; Fredén-Lindqvist J; Bergström GML
Eur J Radiol; 2014 Jul; 83(7):1184-1189. PubMed ID: 24767629
[TBL] [Abstract][Full Text] [Related]
25. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
[TBL] [Abstract][Full Text] [Related]
26. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
[TBL] [Abstract][Full Text] [Related]
27. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Iozzo P; Gastaldelli A; Järvisalo MJ; Kiss J; Borra R; Buzzigoli E; Viljanen A; Naum G; Viljanen T; Oikonen V; Knuuti J; Savunen T; Salvadori PA; Ferrannini E; Nuutila P
J Nucl Med; 2006 Jun; 47(6):1016-22. PubMed ID: 16741312
[TBL] [Abstract][Full Text] [Related]
28. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive quantitative assessment of pulmonary blood flow with 18F-FDG PET.
Pouzot C; Richard JC; Gros A; Costes N; Lavenne F; Le Bars D; Guerin C
J Nucl Med; 2013 Sep; 54(9):1653-60. PubMed ID: 23907755
[TBL] [Abstract][Full Text] [Related]
30. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
Jena A; Taneja S; Goel R; Renjen P; Negi P
Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
[TBL] [Abstract][Full Text] [Related]
31. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
[TBL] [Abstract][Full Text] [Related]
32. Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply.
Brix G; Ziegler SI; Bellemann ME; Doll J; Schosser R; Lucht R; Krieter H; Nosske D; Haberkorn U
J Nucl Med; 2001 Aug; 42(8):1265-73. PubMed ID: 11483690
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
Musiek ES; Saboury B; Mishra S; Chen Y; Reddin JS; Newberg AB; Udupa JK; Detre JA; Hofheinz F; Torigian D; Alavi A
Hell J Nucl Med; 2012; 15(3):190-6. PubMed ID: 23106049
[TBL] [Abstract][Full Text] [Related]
34. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
35. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
36. System approach to modeling of liver glucose metabolism with physiologically interpreted model parameters outgoing from [18F]FDG concentrations measured by PET.
Rausova Z; Chrenova J; Nuutila P; Iozzo P; Dedik L
Comput Methods Programs Biomed; 2012 Aug; 107(2):347-56. PubMed ID: 22465640
[TBL] [Abstract][Full Text] [Related]
37. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
39. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
[TBL] [Abstract][Full Text] [Related]
40. Bringing physiology into PET of the liver.
Keiding S
J Nucl Med; 2012 Mar; 53(3):425-33. PubMed ID: 22323781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
